N. Muszbek
Impact in
- Family Practice top 1%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Co-authors
- Ágnes BenedictA. KeskinaslanZeba KhanJoyce A. CramerNoémi KreifK. Jack IshakStuart CarrollDiana Brixner
- Journals
- Value in Health (9 papers)The European Journal of Health Economics (2 papers)Current Medical Research and Opinion (2 papers)International Journal of Clinical Practice (2 papers)PharmacoEconomics (1 paper)
- Partner nations
- United KingdomUnited StatesHungary
In The Last Decade
N. Muszbek
31 papers receiving 778 citations
Peers
Comparison fields: 5 of 94
- Family Practice 246
- Geriatrics and Gerontology 137
- Economics and Econometrics 237
- Hepatology 68
- Endocrinology, Diabetes and Metabolism 142
Countries citing papers authored by N. Muszbek
This map shows the geographic impact of N. Muszbek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Muszbek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Muszbek more than expected).
Fields of papers citing papers by N. Muszbek
This network shows the impact of papers produced by N. Muszbek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Muszbek. The network helps show where N. Muszbek may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Muszbek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2021 | 2 | |
| 4 | 2019 | 1 | |
| 5 | 2019 | 2 | |
| 6 | 2019 | 10 | |
| 7 | 2016 | 9 | |
| 8 | 2016 | 10 | |
| 9 | 2014 | 21 | |
| 10 | 2013 | 88 | |
| 11 | 2013 | 1 | |
| 12 | 2012 | 1 | |
| 13 | 2011 | 3 | |
| 14 | 2010 | 47 | |
| 15 | 2008 | 71 | |
| 16 | 2008 | 8 | |
| 17 | 2008 | 24 | |
| 18 | 2007 | 389 | |
| 19 | 2006 | 23 | |
| 20 | [Economic evaluation of population-based mass screening for the early detection of cancer: a systematic review]. | 2002 | 1 |
About N. Muszbek
N. Muszbek is a scholar working on Family Practice, Hepatology, Dermatology, Economics and Econometrics and Oncology, having authored 35 papers that have together received 805 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cutaneous lymphoproliferative disorders research (4 papers), Economic and Financial Impacts of Cancer (4 papers), Pharmaceutical Economics and Policy (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and T-cell and Retrovirus Studies (3 papers). The work is most often cited by research in Family Practice (246 citations), Geriatrics and Gerontology (137 citations), Economics and Econometrics (237 citations), Hepatology (68 citations) and Endocrinology, Diabetes and Metabolism (142 citations). N. Muszbek has collaborated with scholars based in United Kingdom, United States and Hungary. Frequent co-authors include Ágnes Benedict, A. Keskinaslan, Zeba Khan, Joyce A. Cramer, Noémi Kreif, K. Jack Ishak, Stuart Carroll, Diana Brixner, Kathleen Gondek and Brian I. Carr. Their work appears in journals such as Value in Health, The European Journal of Health Economics, Current Medical Research and Opinion, International Journal of Clinical Practice and PharmacoEconomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.